Landauer Radiopharmaceuticals

Landauer is a global leader in radiation science and dosimetry services, providing critical support for the healthcare and life sciences industries. The company specializes in radiopharmaceutical dosimetry (RPD), offering specialized services that enable the precise measurement of internal radiation doses during the development and clinical application of molecular radiotherapies. Landauer’s proprietary Optically Stimulated Luminescence (OSL) technology is a global standard for monitoring occupational radiation exposure for medical personnel. By partnering with pharmaceutical companies, Landauer ensures patient safety and regulatory compliance in the rapidly growing field of targeted alpha and beta therapies. The company was acquired by Fortive in 2017 and currently operates within its Fluke Health Solutions division.